Abstract
Chinese wolfberries have been proved to have an antitumor effect and to be less toxic. Lycium barbarum polysaccharide (LBP) isolated from aqueous extracts of L. barbarum has been identified as one of the major active ingredients that are responsible for the biological activities. LBP significantly affects the vascular endothelial growth factor (VEGF) and cyclin D1 protein expression in liver cancer. It inhibits gastric ulcer development and reduces the incidence of gastric cancer. Induction of cell-cycle arrest participates in the anticancer activity of LBP on gastric cancer cells. LBP has an antitumor effect probably by increasing the number of CD4 + T cells in tumor-infiltrating lymphocytes (TIL) to relieve the immunosuppression and enhance the antitumor function of the immune system. LBP inhibits the growth of colorectal tumor cells by inhibiting the expression of Livin and Bcl-2 and induces the apoptosis of tumor cells. LBP also has a long-term antiproliferative effect on colon cancer. These results provide a theoretical basis for the clinical use of Chinese wolfberries in the prevention and treatment of tumors in the gastrointestinal tract.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abrams SI. Position and negative consequences of Fas/Fas ligand interactions in the antitumor response. Front Biosci. 2008;10:809–21.
Alvarsson M, et al. Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up. Diabetes Obes Metab. 2008;10(5):421–9.
Amagase H, Nance DM. A randomized, double-blind, placebo controlled clinical study of the general effects of a standardized Lycium barbarum (goji) juice, GoChi. J Alt Comp Med. 2008;14(4):403–12.
Arslan AA, et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Arch Intern Med. 2010;170(9):791–802.
Chen CJ, et al. Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol. 2002;32 (Suppl):S66–81.
Chen JR, et al. The inducible effect of LBP on maturation of dendritic cells and the related immune signaling pathways in hepatocellular carcinoma (HCC). Curr Drug Deliv. 2012;9(4):414–20.
Cui B, et al. Antitumour activity of Lycium chinensis polysaccharides in liver cancer rats. Int J Biol Macromol. 2012;51(3):314–8.
Cui L, et al. Gastric juice microRNAs as potential biomarkers for the screening of gastric cancer. Cancer. 2013;119(9):1618–26.
Culen JJ, et al. Gastrointestinal myoelectric actively during endotoxemic. Am J Surg. 1996;171(6):596–9.
Diederichsen AC, et al. Prognostic value of the CD4+/CD8+ ratio of the tumour infiltrating Lymphocytes in colorectal cancer and HLA-DR expression on tumour cell. Cancer Immunol Immunother. 2003;52(7):423–8.
Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA. 1995;273(20):1605–9.
Ferlay J, et al. Globocan 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No.5, Version 2.0. Lyon: IARC Press; 2004.
Ferlay J, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.
Gan L, et al. Immunomodulation and antitumor activity by a polysaccharide protein complex from Lycium barbarum. Int Immunopharmacol. 2004;4(4):563–9.
Gavin AT, et al. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36(6):505–12.
Goldman R. Characteristics of the beta-glucan receptor of murine macrophages. Exp Cell Res. 1988;174(2):481–90.
Grulich AE, et al. Cancer incidence in Asian migrants to New South Wales, Australia. Br J Cancer. 1995;71(2):400–8.
Guyton KZ, Kensler TW. Oxidative mechanisms in carcinogenesis. Br Med Bull. 1993;49(3):523–44.
Hassan MM, et al. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol. 2007;102(12):2696–707.
Hatakeyama S, et al. Targeted destruction of c-Myc by an engineered ubiquitin ligase suppresses cell transformation and tumor formation. Cancer Res. 2005;65(17):7874–9.
He YL, et al. Effects of Lycium barbarum polysaccharide on tumor microenvironment T-lymphocyte subsets and dendritic cells in H22-bearing mice. Zhong Xi Yi Jie He Xue Bao. 2005;3(5):374–7.
Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol. 2007;17(1):2–9.
Iodice S, et al. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008;393(4):535–45.
Jemal A, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49.
Jemal A, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.
Jiao L, et al. Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control. 2010;21(8):1305–14.
Kasof GM, Gomes BC. Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem. 2001;276(5):3238–46.
Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell. 2001;106(3):263–6.
Lee BN, et al. Depressed type 1 cytokine synthesis by superantigen-related high-grade squamous intraepithelial lesions. Clin Diag Lab Immunol. 2004;11(2):239–44.
Li XM. Protective effect of Lycium barbarum polysaccharides on streptozotocin-induced oxidative stress in rats. Int J Biol Macromol. 2007;40(5):461–5.
Lin JI-I, et al. KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun. 2000;279(3):820–31.
Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 2001;106(3):259–62.
Lynch SM, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol. 2009;170(4):403–13.
Mangtani P, et al. Cancer mortality in ethnic South Asian migrants in England and Wales (1993–2003): patterns in the overall population and in first and subsequent generations. Br J Cancer. 2010;102(9):1438–43.
Mao F, et al. Anticancer effect of Lycium barbarum polysaccharides on colon cancer cells involves G0/G1 phase arrest. Med Oncol. 2011;28(1):121–6.
Mckinnon CM, Docherty K. Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia. 2001;44(10):1203–14.
Miao Y, et al. Growth inhibition and cell-cycle arrest of human gastric cancer cells by Lycium barbarum polysaccharide. Med Oncol. 2010;27(3):785–90.
Michaud DS, et al. Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes Control. 2010;21(8):1213–25.
Nishiura H, et al. Interleukin-21 and tumor necrosis factor-α are critical for the development of autoimmune gastritis in mice. J Gastroenterol Hepatol. 2013;28(6):982–91.
Pan H, et al. Apoptosis and cancer mechanism. Cancer Surv. 1997;29:305–27.
Peter L, et al. The inhibitors of apoptosis: there is more to life than Bcl-2. Oncogene. 2003;22(53):8568–80.
Seder RA, Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T cells generation. Nat Immunol. 2003;4(9):835–42.
Siegel R, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220–41.
Siewert JR, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the Western world. Ann Surg. 2001;234(3):360–7.
Sinicrope FA, et al. Bcl-2 and P53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 1995;55(2):237–41.
Song B, et al. Chop deletion reduces oxidative stress, improves B cell function and promotes cell survival in multiple mouse models of diabetes. J Clin Invest. 2008;118(10):3378–89.
Stephens KE, et al. Tumor necrosis factor cause increased pulmonary and edema. Comparison to septic acute lung injury. Am Rev Respir Dis. 1988;137(6):1364–70.
Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein products ofbcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci U S A. 1986;83(14):5214–8.
Tu RSP, et al. A cross-border comparison of hepatitis B testing among Chinese residing in Canada and the United States. Asian Pac J Cancer Prev. 2009;10(3):483–90.
Vucic D, et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol. 2000;10(21):1359–66.
Wang R, et al. Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein. J Immunol. 2004;172(9):5561–9.
Wogan GN. Dietary risk factors for primary hepatocellular carcinoma. Cancer Detect Prev. 1989;14(2):209–13.
Wu J, et al. Significance of apoptosis and apoptofic-related proteins, Bcl-2 and Bax in primary breast cancer. Breast J. 2006;6(1):44–52.
Zhu KJ. Dendritic cell and autoimmune diseases. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2003;32(1):81–4.
Zhu Q, et al. Mechanism of counter attack of colorectal cancer cell by Fas/Fas ligand system. World J Gastroenterol. 2005;11(39):6125–9.
Zimmerli SC, et al. HIV-1-specific INF-γ/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci U S A. 2005;102(20):7239–44.
Acknowledgments
This work was supported by the Student Innovation and Open Laboratory Program of Ningbo University (No. Cxxkf 2008-066), the Student Research and Innovation Program of Ningbo University (2008), the Scientific Innovation Team Project of Ningbo (No. 2011B82014), the Project of Key Disciplines in Ningbo (No. XKL11D2127 and No. XKL11D2128), the Foundation of Zhejiang Provincial Key Laboratory of Pathophysiology (No. 201301), and the K. C. Wong Magna Fund in Ningbo University.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Li, P., Xiao, B., Chen, H., Guo, J. (2015). Lycium Barbarum and Tumors in the Gastrointestinal Tract. In: Chang, RC., So, KF. (eds) Lycium Barbarum and Human Health. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9658-3_6
Download citation
DOI: https://doi.org/10.1007/978-94-017-9658-3_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-9657-6
Online ISBN: 978-94-017-9658-3
eBook Packages: MedicineMedicine (R0)